Hepatology | Links Medicus Content Curation & Alerts in Medicine

This #RCT examined the use of rivaroxaban to reduce risk of venous thromboembolism (VTE) in pts with non-cirrhotic chronic portal vein thrombosis (PVT). Daily rivaroxaban reduced incidence of VTE and did not increase major bleeding events. https://t.co/CbenUb8ZWz #LiverTwitter pic.twitter.com/bgN1QS171j

— NEJM Evidence (@NEJMEvidence) November 22, 2022

Review | Public health measures and prevention of alcohol-associated liver disease.

27 Nov, 2022 | 22:14h | UTC

Public Health Measures and Prevention of Alcohol-Associated Liver Disease – Journal of Clinical and Experimental Hepatology

Commentary from one of the authors on Twitter

Public Health Measures and Prevention of Alcohol-Associated Liver Disease @JCEH_Hepatology @LuisAntonioDiaz @FcoIdalsoaga @CokeArnold1 #LiverTwitter https://t.co/8pVLg5Kffp pic.twitter.com/OCrIYgVhJa

— Juan Pablo (JP) Arab, MD (@juanpabloarab) June 28, 2022

KDIGO 2022 Guideline for the prevention, diagnosis, evaluation, and treatment of Hepatitis C in chronic kidney disease.

23 Nov, 2022 | 14:11h | UTC

KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease – Kidney International

Executive Summary: KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease – Kidney International

News Release: KDIGO Announces Publication of 2022 Hepatitis C in Chronic Kidney Disease Guideline – Kidney Disease: Improving Global Outcomes (KDIGO)

Expert consensus on liver transplantation perioperative evaluation and rehabilitation for acute-on-chronic liver failure.

21 Nov, 2022 | 14:21h | UTC

Expert consensus on liver transplantation perioperative evaluation and rehabilitation for acute-on-chronic liver failure – Liver Research

Portopulmonary hypertension: current developments and future perspectives.

21 Nov, 2022 | 14:20h | UTC

Portopulmonary hypertension: Current developments and future perspectives – Liver Research

Pulmonary complications of hepatic diseases – World Journal of Gastroenterology 

Pulmonary Vascular Complications of Liver Disease – American Journal of Respiratory and Critical Care Medicine

Phase 2b RCT | Efficacy and safety of Bepirovirsen in chronic Hepatitis B infection.

11 Nov, 2022 | 13:44h | UTC

Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary on Twitter

In a phase 2 trial, bepirovirsen, an antisense oligonucleotide that targets all hep B virus (HBV) messenger RNAs, resulted in sustained loss of hep B surface antigen and HBV DNA in 9 to 10% of participants with chronic HBV infection. #TLM22 #LiverTwitter https://t.co/krJcMEDhIX pic.twitter.com/SistuAocZO

— NEJM (@NEJM) November 8, 2022

Retrospective Cohort Study | Perinatal outcomes associated with ICP in twin pregnancies were worse than singletons.

11 Nov, 2022 | 13:36h | UTC

Perinatal outcomes associated with ICP in twin pregnancies were worse than singletons: an almost 5-year retrospective cohort study – BMC Pregnancy and Childbirth

M-A | Efficacy and safety of pharmacological interventions for pruritus in primary biliary cholangitis.

8 Nov, 2022 | 11:58h | UTC

Efficacy and safety of pharmacological interventions for pruritus in primary biliary cholangitis: A systematic review and meta-analysis – Frontiers in Pharmacology

Review | Determining prognosis of alcoholic liver disease and alcoholic hepatitis.

4 Nov, 2022 | 13:17h | UTC

Determining Prognosis of ALD and Alcoholic Hepatitis – Journal of Clinical and Experimental Hepatology

ERAS Guidelines for perioperative care for liver surgery.

1 Nov, 2022 | 12:16h | UTC

Guidelines for Perioperative Care for Liver Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations 2022 – World Journal of Surgery

Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines

Top 100 Most-Cited Articles on Enhanced Recovery After Surgery: A Bibliometric Analysis and Visualized Study – Frontiers in Surgery

Review | Management of NAFLD in primary care settings.

27 Oct, 2022 | 12:24h | UTC

Management of NAFLD in primary care settings – Liver International

Updated S2k Clinical Practice Guideline on Non-alcoholic Fatty Liver Disease (NAFLD) issued by the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) – Zeitschrift für Gastroenterologie

AGA Clinical Practice Update | Diagnosis and management of nonalcoholic fatty liver disease in lean individuals.

Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group – The Lancet Gastroenterology & Hepatology (free registration required)

Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association – Arteriosclerosis, Thrombosis, and Vascular Biology

Advancing the global public health agenda for NAFLD: a consensus statement – Nature Reviews Gastroenterology & Hepatology

Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease – Gastroenterology

Non-alcoholic fatty liver disease: A patient guideline – JHEP Reports

Commentary on Twitter

Opportunities of assessment and treatment of #NAFLD in primary care settings

👉 https://t.co/cXJHFRiJVn

✍️ @VWSWong @DrJavierCrespo @JVLazarus #livertwitter #liverreviews #NASH pic.twitter.com/5SLqNvafAm

— Liver International (@LiverInt) October 23, 2022

AHA Scientific Statement | Emerging evidence on coronary heart disease screening in kidney and liver transplantation candidates.

24 Oct, 2022 | 14:11h | UTC

Emerging Evidence on Coronary Heart Disease Screening in Kidney and Liver Transplantation Candidates: A Scientific Statement From the American Heart Association – Circulation (PDF)

Top Things to Know: Emerging Evidence on Coronary Heart Disease (CHD) Screening in Kidney and Liver Transplantation Candidates – American Heart Association

Commentary: Trials and Tribulations of Cardiac Screening Asymptomatic Kidney and Liver Transplant Candidates – American Heart Association

Case-control study | Post-paracentesis ascitic fluid leak in patients with cirrhosis of liver and its management.

21 Oct, 2022 | 12:57h | UTC

Post-Paracentesis Ascitic Fluid Leak in Patients with Cirrhosis of Liver and its Management: A Prospective Study – Journal of Clinical and Experimental Hepatology

M-A of RCT | Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis.

20 Oct, 2022 | 12:25h | UTC

Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis – Journal of Hepatology (link to abstract – $ for full-text)

Commentary on Twitter

#Carvedilol
➡️non-selective #βblocker
✅associated with reduced risk of decompensating events
➡️improved survival in patients with #cirrhosis & #portalhypertension

Read it here👉https://t.co/yy8DIJBhfL #LiverTwitter pic.twitter.com/XxmrB7gff8

— Journal of Hepatology (@JHepatology) October 13, 2022